Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
The class now includes three types: GLP-1 agonists: Activate the GLP-1 receptor only (semaglutide, liraglutide, exenatide, dulaglutide, lixisenatide, orforglipron) Dual GLP-1/GIP agonists: Activate both GLP-1 and GIP receptors (tirzepatide) Triple agonists (investigational): Activate GLP-1, GIP, and glucagon receptors (retatrutide, in Phase 3 trials) GLP-1 Medications Compared: Full Comparison Chart Here's every GLP-1 medication currently FDA-approved, with the data you actually need to compare them side by side
Broader questions about peptide legality , drug testing , and vendor selection are covered in their respective guides
Figure 1 Statements Author contributions RC: Writing review & editing, Writing original draft
These findings suggest that the nootropic compound elicits neuroprotective effects on nerve cells in the brain damaged by inflammatory factors [1]
